Halifax, NS – Scientists at Dalhousie University have identified a key mechanism of metastasis that could lead to blocking tumour growth if their findings are confirmed.
In the November 1 issue of Cancer Research, a journal of the American Association for Cancer Research, lead researcher Dr David Waisman, professor in the Departments of Biochemistry and Molecular Biology and Pathology, and Canada Research Chair in Cancer Research at Dalhousie University, detail the key role the macrophage cell surface protein S100A10 plays in allowing macrophages to move to the site of tumour growth – a process that is essential to tumour development.
Dr Waisman said the findings are an example of the complicated biology of cancer.
“We used to think that the only cells that mattered in a tumour were the cancer cells, and that’s it, but now we are beginning to see that other cells must collaborate with cancer cells to drive tumour growth and permit an evolution of the cancer cells into metastatic cells. This change is what causes poor prognosis and ultimately what kills the patient,” he said.
Dr Waisman and colleagues discovered that tumours will not grow without macrophage assistance. These macrophages must come from the blood or from other locations in the tissues. How they are able to move through the tissues or from the blood supply into the tumour had always been a mystery.
These macrophages need to chew their way through the tissue that forms a barrier around the growing tumour in order to move into the tumour site and combine with the cancer cells. The researchers found on the outside surface of the macrophage is a protein called S100A10, which enables the macrophage to remove the tissue barriers retarding migration to the tumour site.
Theoretically, blocking either the macrophages or S100A10 chemically could slow, or even stop, tumour growth.
“We found that the protein, S100A10, acts like a pair of scissors on the outside of the macrophages that empowers the macrophages with the ability to chew their way through tissues and enter the tumour site where they release substances that stimulate cancer cell growth and metastatic evolution,” said Dr Waisman.
He said the next step is to figure out exactly how S100A10 functions as a molecular scissor and also to identify pharmaceutical agents that can block the action of S100A10, thereby preventing the movement of macrophages to the tumour site. By understanding exactly how S100A10 works at the molecular level, it may even be possible to design agents which block its activity.